<DOC>
<DOCNO>EP-0625983</DOCNO> 
<TEXT>
<INVENTION-TITLE>
HETEROTRICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31535	A61K31535	A61K315375	A61K315383	A61K3154	A61K3154	A61K31542	A61K31542	A61P2900	A61P2900	A61P3500	A61P3500	A61P3504	A61P3700	A61P3706	C07D49800	C07D49806	C07D51300	C07D51306	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P29	A61P29	A61P35	A61P35	A61P35	A61P37	A61P37	C07D498	C07D498	C07D513	C07D513	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Heterotricyclic derivatives of formula (I) wherein R
<
1
>
 is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen, nitro, amino or protected amino, R
<
2
>
 is hydroxy, protected hydroxy, halogen, amino or protected amino, R
<
3
>
 is hydrogen or an organic group, R
<
4
>
 is hydrogen or lower alkyl, R
<
8
>
 is hydrogen or lower alkyl, and -Z- is -O- or a group of formula (II) (in which n is 0, 1 or 2), and pharmaceutically acceptable salts thereof which are useful as a medicament.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
FUJISAWA PHARMACEUTICAL CO
</APPLICANT-NAME>
<APPLICANT-NAME>
FUJISAWA PHARMACEUTICAL CO., LTD.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
MATSUO MASAAKI
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKAMURA KATSUYA
</INVENTOR-NAME>
<INVENTOR-NAME>
SPEARS GLEN W
</INVENTOR-NAME>
<INVENTOR-NAME>
TSUJI KIYOSHI
</INVENTOR-NAME>
<INVENTOR-NAME>
MATSUO, MASAAKI
</INVENTOR-NAME>
<INVENTOR-NAME>
NAKAMURA, KATSUYA
</INVENTOR-NAME>
<INVENTOR-NAME>
SPEARS, GLEN, W.
</INVENTOR-NAME>
<INVENTOR-NAME>
TSUJI, KIYOSHI
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing themDESCRIPTIONTECHNICAL FIELDThis relates to new heterotricyclic derivatives and pharmaceutically acceptable salts thereof which are useful 10 as a medicament.BACKGROUND ARTSome heterotricyclic derivatives have been known as described, for example, in U.S. Patent 4,547,511. 15DISCLOSURE OF INVENTIONThis invention relates to new heterotricyclic derivatives. More particularly, this invention relates to20 new heterotricyclic derivatives and pharmaceutically acceptable salts thereof which have pharmacological activities, processes for preparation thereof, a pharmaceutical composition comprising the same and a use of the same.25 Accordingly, one object of this invention is to provide the new and useful heterotricyclic derivatives and pharmaceutically acceptable salts thereof which possess a strong immunomodulating activity (e.g. an inhibitory activity on the production of an autoantibody, etc.),30 anti-inflammatory activity and anti-cancer activity. Another object of this invention is to provide processes for preparation of the heterotricyclic derivatives and salts thereof.A further object of this invention is to provide a35 pharmaceutical composition comprising said heterotricyclic derivatives or a pharmaceutically acceptable salt thereof. 

 Still further object of this invention is to provide a use of said heterotricyclic derivatives or a pharmaceutically acceptable salt thereof as a medicament for the treatment and/or prevention of inflammatory conditions, various pains, collagen diseases, autoimmune diseases, various immunity diseases, cancer and the like in human being and animals.The object heterotricyclic derivatives of the present invention are novel and can be represented by the following general formula (I) :wherein R is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen, nitro, amino or protected amino,R' is hydroxy, protected hydroxy, halogen, amino or protected amino, is hydrogen or an organic group,R' is hydrogen or lower alkyl, is hydrogen or lower alkyl, and-Z- is -O- or a group of the formula-S- 
(in which n is 0, 1 or 2) .The object compound (I) of the present invention can be prepared by the following processes. 

Process ( 1 )H(ID or a salt thereofR3-CH(COR5)2(III) or a salt thereof(Ia) or a salt thereofProcess (2)(lb) or its reactive derivative at the carboxy group, or a salt thereof 

 Amidation reaction(Ic) or a salt thereofProcess (3)(IV) or a salt thereofElimination
</DESCRIPTION>
<CLAIMS>
C L I M S
A compound of the formula
wherein R is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen, nitro, amino or protected amino,
R2 is hydroxy, protected hydroxy, halogen, amino or protected amino,
3 R is hydrogen or an organic group,
4 R is hydrogen or lower alkyl,
R is hydrogen or lower alkyl, and
-Z- is -O- or a group of the formula :
-S- 
<
0)
n
(in which n is 0, 1 or 2),
and a pharmaceutically acceptable salt thereof,
2. A compound of claim 1, wherein R is hhyyddrrooggeenn,, lloowweerr aallkkyyll,, llcower alkoxy, lower alkylthio, halogen, nitro, amino or acylamino,
2 R is hhyydd-rsoxy, acyloxy, halogen, amino or acylamino and
3 . R is carboxy or acyl, 


3. A compound of claim 2, wherein
R is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen, nitro, amino or lower alkanoylamino, 2 R is hydroxy, lower alkanoyloxy, halogen, amino or acylamino, and 3 R is carboxy, lower alkoxycarbonyl, heterocycliccarbonyl which may have one to three suitable substituent(s) or carbamoyl which may have one or two suitable substituent(s) .
4. A compound of claim 3, wherein
R is carboxy; lower alkoxycarbonyl; indolinylcarbonyl, tetrahydroquinolylcarbonyl, tetrahydroisoquinolylcarbonyl, tetrahydroquinoxalinylcarbonyl, dihydrobenzoxazinylcarbonyl or dihydrobenzothiazinylcarbonyl, each of which may have one to three substituent(s) selected from the group consisting of halogen, nitro, lower alkyl, lower alkoxy, carboxy and protected carboxy; or carbamoyl which may have one or two substituent(s) selected from the group consisting of lower alkyl and aryl which may have one to three suitable substituent(s) .
5. A compound of claim 4, wherein
3 R is carboxy; lower alkoxycarbonyl; indolinylcarbonyl, tetrahydroquinolylcarbonyl, tetrahydroisoquinolylcarbonyl, tetrahydroquinoxalinylcarbonyl , dihydrobenzoxazinylcarbonyl or dihydrobenzothiazinylcarbonyl, each of which 


 may have one or two substituent(s) selected from the group consisting of halogen, nitro, lower alkyl, lower alkoxy, carboxy and esterified carboxy; or carbamoyl which may have one or two substituent(s) selected from the group consisting of lower alkyl, aryl, haloaryl, lower alkylthioaryl, lower alkylsulfinylaryl and acylaryl.
6. A compound of claim 5, wherein
R is carboxy; lower alkoxycarbonyl; indolinylcarbonyl, tetrahydroquinolylcarbonyl, tetrahydroisoquinolylcarbonyl, tetrahydroquinoxalinylcarbonyl, dihydrobenzoxazinylcarbonyl or dihydrobenzothiazinylcarbonyl, each of which may have one or two substituent(s) selected from the group consisting of halogen, nitro, lower alkyl, lower alkoxy, carboxy and esterified carboxy; or carbamoyl which may have one or two substituent(s) selected from the group consisting of lower alkyl, phenyl, halophenyl, lower alkylthiophenyl, lower alkylsulfinylphenyl and lower alkylsulfonylphenyl.
7. A compound of claim 6, wherein R is hydrogen or lower alkoxy,
2 R is hydroxy,
3 R is indolinylcarbonyl which may have halogen or lower alkyl, or carbamoyl which may have one or two substituent(s) selected from the group consisting of lower alkyl, phenyl, halophenyl, 


 lower alkylsulfinylphenyl and lower alkylsulfonylphenyl, 4 . R is hydrogen, p
R is hydrogen, and
-Z- is -0- or a group of the formula :
-S- 

10 (in which n is 1)
8. A compound of claim 7, which is selected from the group consisting of
2,3-Dihydro-6-(4-fluoro-l-indolinylcarbonyl)-7- «
5
 hydroxy-9-metoxy-5-oxo-5H-pγrido[l,2,3-de]-1,4- benzoxazine,
2,3-Dihγdro-7-hydroxy-9-methoxy-6-(5-methyl-l- indolinylcarbonyl)-5-oxo-5H-pyrido[1,2,3-de]-1,4- 2
Q
 benzoxazine,
2,3-Dihydro-7-hydroxy-6-[N-(4-fluorophenyl)-N- methylcarbamoyl]-5-oxo-5H-pyrido[l,2,3-de]
-1,4- benzoxazine,
25
6-[N-Methyl-N-(4-methylsulfinylphenyl)carbamoyl]-
2,3-dihydro-7-hydroxy-5-oxo-5H-pyrido[l,2,3-de]-l,4- benzoxazine,
30
 6-[N-Methyl-N-(4-methylsulfonylphenyl)carbamoyl]-
2,3-dihydro-7-hydroxy-5-oxo-5H-pyrido[1,2,3-de]-1,4- benzoxazine,
2,3-Dihydro-7-hydroxy-9-methoxy-6-(N-methγl-N- 25 phenylcarbamoyl)-5-oxo-5H-pγrido[1,2,3-de]-1,4- 



 benzothiazine 1-oxide and
2,3-Dihydro-7-hydroxy-6-(N-methyl-N-phenylcarbamoyl)' 5-oxo-5H-pyrido[1,2,3-de]-1,4-benzothiazine-l-oxide.
9. A process for preparing a compound of the formula :
wherein R is hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogen, nitro, amino or protected amino, 2 R is hydroxy, protected hydroxy, halogen, amino or protected amino, _ R3 i•s ,hyd,rogen or an organic group,
4
R is hydrogen or lower alkyl, o
R is hydrogen or lower alkyl, and
-Z- is -0- or a group of the formula
-S- 

(in which n is 0, 1 or 2) , or a salt thereof, which comprises
(1) reacting a compound of the formula : 

wherein R 1, R4, R8 and -Z- are each as defined above, or a salt thereof with a compound of the formula :
R
3
-CH(COR
5
)
wherein R is as defined above and
R is a leaving group, or a salt thereof to give a compound of the formula
wherein R , R , R , R and -Z- are each as defined above, or a salt thereof, or
(2) subjecting a compound of the formula

 55 -
wherein R 1, R2, R4, R8 and -Z- are each as defined above, or its reactive derivative at the carboxy group, or a salt thereof to amidation reaction to give a compound of the formula :
wherein R
'
 , R , R , R and -Z- are each as defined
15 above, and a group of the formula :
- -CCOORR iiss aammiiddated carboxy, or a salt thereof, or
20 (3) subjecting a compound of the formula
30 wherein R , R , R , R and -Z- are each as defined above, and R ,7' is protected carboxy, or a salt thereof to elimination reaction of the carboxy protective group to give a compound of the
35 formula : 

wherein R , R , R , R and -Z- are each as defined above, or a salt thereof, or
(4) subjecting a compound of the formula
wherein R , R , R , R and R are each as defined above, or a salt thereof to oxidation reaction to give a compound of the formula :
wherein R , R , R , R and R are each as defined above, and 


 m is 1 or 2, or a salt thereof, or
(5) subjecting a compound of the formula
wherein R , R , R , R and -Z- are each as defined above, or a salt thereof to halogenation reaction to give a compound of the formula :
wherein R , R , R , R and -Z- are each as defined above, and
2 Ra is halogen, or a salt thereof, or 
~~
(6) subjecting a compound of the formula 

wherein R , Rcl, R , R , R and -Z- are each as defined above, or a salt thereof to animation reaction to give a compound of the formula :
wherein R , R , R , R and -Z- are each as defined above, or a salt thereof, or
(7) reacting a compound of the formula
wherein R 1, R4, R8 and -Z- are each as defined above, or a salt thereof with a compound of the formula : 


 9 " 3
R -C-CH
2
-R
wherein R is as defined above, and 9 R is a leaving group, or a salt thereof to give a compound of the formula
wherein R , R , R , R and -Z- are each as defined above, or a salt thereof, or
(8) subjecting a compound of the formula
wherein R , R , R , R and -Z- are each as defined above, or a salt thereof to reduction reaction to give a compound of the formula : 

wherein R", R , R , R and -Z- are each as defined above, or a salt thereof, or
(9) subjecting a compound of the formula
wherein R , R , R , R and Z are each as defined above, or a salt thereof to acylation reaction to give a compound of the formula :
wherein R', R , R , R and -Z- are each as defined above, and 


 R is acylamino, or a salt thereof, or (10) subjecting a compound of the formula
wherein R , R , R , R and -Z- are each as defined above, or a salt thereof to acylation reaction to give a compound of the formula :
wherein R , R , R , R and -Z- are each as defined above, and
R, is acyloxy, or a salt thereof, or (11) subjecting a compound of the formula :

 -j * A Q wherein R , R", R , R and -Z- are each as defined above, and
R ,3 is acyl having protected carboxy, or a salt thereof to elimination reaction of the carboxy protective group to give a compound of the formula :
wherein R , R , R , R and -Z- are each as defined above, and 3 R, is acyl having carboxy, or a salt thereof, or
(12) subjecting a compound of the formula :
30 wherein R , R , R , R and -Z- are each as defined above, and 3 R
^
 is acyl having lower alkylthio, or a salt thereof to oxidation reaction to give a compound of the formula :
35 

wherein R , R^, R , R and -Z- are each as defined above, and
R ,3, i.s acyl having lower alkylsulfinyl or lower alkylsulfonyl, or a salt thereof.
10. A pharmaceutical composition which comprises, as an active ingredient, a compound of claim 1 or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers.
11. A use of a compound of claim 1 or a pharmaceutically acceptable salt thereof as immunomodulating agent, anti-inflammatory agent or anti-cancer agent.
12. A method for the prophylactic or therapeutic treatment of inflammatory conditions, various pains collagen diseases, autoimmune diseases, various immunity diseases or cancer which comprises administering a compound of claim 1 or a pharmaceutically acceptable salt thereof to human or animals.
13. A process for preparing a pharmaceutical composition which comprises admixing a compound of claim 1 or a pharmaceutically acceptable salt thereof with a pharmaceutically acceptable carrier. 

</CLAIMS>
</TEXT>
</DOC>
